📊 The healthcare sector is witnessing diverse performance outcomes based on short to mid-term evaluations across its major stocks. The sector shows resilience and volatility influenced by external macroeconomic factors and internal industry shifts. Identifying key top performers and underperformers is crucial for investors to navigate through the sector's dynamic landscape.
| Stock | Performance (%) | Performance |
|---|---|---|
| JNJ | 3.45 | |
| UNH | 2.28 | |
| AMGN | 1.73 | |
| ABBV | 0.25 | |
| LLY | 0.20 | |
| TMO | -0.55 | |
| MRK | -1.43 | |
| ISRG | -2.57 | |
| ABT | -3.18 |
| Stock | Performance (%) | Performance |
|---|---|---|
| LLY | 12.44 | |
| AMGN | 8.76 | |
| ABBV | 8.11 | |
| TMO | 7.35 | |
| MRK | 7.08 | |
| JNJ | 6.19 | |
| ABT | 4.58 | |
| UNH | 3.93 | |
| ISRG | -2.01 |
| Stock | Performance (%) | Performance |
|---|---|---|
| UNH | 37.25 | |
| LLY | 15.37 | |
| MRK | 3.96 | |
| ABBV | 3.62 | |
| TMO | 1.42 | |
| JNJ | -0.57 | |
| AMGN | -2.31 | |
| ISRG | -14.89 | |
| ABT | -21.18 |
🔍 The healthcare sector, over the different timeframes, displays substantial fluctuation in stock behaviours. Over the short term, Eli Lilly (LLY) and UnitedHealth Group (UNH) present robust growth, while Abbott Laboratories (ABT) faces challenges, reflected in its downward trajectory over longer periods. Investors should consider this variability as both a risk and an opportunity, depending on their market strategies. Future investment decisions should weigh macroeconomic conditions, healthcare innovations, and regulatory changes.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.